Literature DB >> 31340008

Data Resource Profile: The Systemic Anti-Cancer Therapy (SACT) dataset.

Chloe J Bright1, Sarah Lawton1, Stephen Benson1, Martine Bomb1, David Dodwell2, Katherine E Henson1, Sean McPhail1, Louise Miller1, Jem Rashbass1, Alice Turnbull1, Rebecca Smittenaar1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31340008     DOI： 10.1093/ije/dyz137

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  13 in total

1.  Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy.

Authors:  Lars Børty; Rasmus F Brøndum; Heidi S Christensen; Charles Vesteghem; Marianne Severinsen; Søren P Johnsen; Lars H Ehlers; Ursula Falkmer; Laurids Ø Poulsen; Martin Bøgsted
Journal:  Eur J Health Econ       Date:  2022-08-26

2.  Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies: A National Registry Dataset Analysis.

Authors:  Nicolò Matteo Luca Battisti; Catherine A Welch; Michael Sweeting; Mark de Belder; John Deanfield; Clive Weston; Michael D Peake; David Adlam; Alistair Ring
Journal:  JACC CardioOncol       Date:  2022-06-21

3.  Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries.

Authors:  Alice Pisana; Björn Wettermark; Amanj Kurdi; Biljana Tubic; Caridad Pontes; Corinne Zara; Eric Van Ganse; Guenka Petrova; Ileana Mardare; Jurij Fürst; Marta Roig-Izquierdo; Oyvind Melien; Patricia Vella Bonanno; Rita Banzi; Vanda Marković-Peković; Zornitsa Mitkova; Brian Godman
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

4.  Data Resource Profile: The Virtual Cardio-Oncology Research Initiative (VICORI) linking national English cancer registration and cardiovascular audits.

Authors:  Michael J Sweeting; Clare Oliver-Williams; Lucy Teece; Catherine A Welch; Mark A de Belder; Briana Coles; Paul C Lambert; Lizz Paley; Mark J Rutherford; Lucy Elliss-Brookes; John Deanfield; Mick D Peake; David Adlam
Journal:  Int J Epidemiol       Date:  2021-06-05       Impact factor: 7.196

5.  Comparing Findings From a Friends of Cancer Research Exploratory Analysis of Real-World End Points With the Cancer Analysis System in England.

Authors:  Pia Horvat; Christen M Gray; Alexandrina Lambova; Jennifer B Christian; Laura Lasiter; Mark Stewart; Jeff Allen; Paul Clarke; Cong Chen; Adam Reich
Journal:  JCO Clin Cancer Inform       Date:  2021-12

6.  Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England.

Authors:  L Hounsome; T A Eyre; R Ireland; A Hodson; R Walewska; K Ardeshna; S Chaganti; P McKay; A Davies; C P Fox; N Kalakonda; P A Fields
Journal:  Br J Cancer       Date:  2021-10-05       Impact factor: 7.640

7.  What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and validation study using linked English electronic health records data.

Authors:  Helen Strongman; Rachael Williams; Krishnan Bhaskaran
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

8.  Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018.

Authors:  Ruth Board; Rebecca Smittenaar; Sarah Lawton; Hanhua Liu; Bukky Juwa; David Chao; Pippa Corrie
Journal:  Int J Cancer       Date:  2020-09-12       Impact factor: 7.396

9.  Data Resource Profile: The COloRECTal cancer data repository (CORECT-R).

Authors:  Amy Downing; Peter Hall; Rebecca Birch; Elizabeth Lemmon; Paul Affleck; Hannah Rossington; Emily Boldison; Paul Ewart; Eva J A Morris
Journal:  Int J Epidemiol       Date:  2021-11-10       Impact factor: 7.196

Review 10.  Identifying options for oncology therapy regimen codification to improve standardization-combined results of an expert panel and a review.

Authors:  Robert Terkola; Christophe Bardin; Garbiñe Lizeaga Cundin; Nadine Zeinab; Mirjam Crul
Journal:  J Clin Pharm Ther       Date:  2021-03-09       Impact factor: 2.512
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.